Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• The Future of Drug Safety: Promoting and Protecting the Health of the Public (2007) (ISBN 0309103045) Committee on the Assessment of the US Drug Safety System, Alina Baciu, Kathleen Stratton, Sheila P. Burke, Editors


• Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary (2012) (ISBN 0309253152) Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy; Institute of Medicine


• Transforming Clinical Research in the United States: Challenges and Opportunities: Workshop Summary (2010) (ISBN 0309153328) Rebecca English, Yeonwoo Lebovitz, and Robert Griffin, authors; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Ethical and Scientific Issues in Studying the Safety of Approved Drugs (2012) (ISBN 0309218136) Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs; Institute of Medicine


• A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program (2010) (ISBN 0309151864) Sharyl J. Nass, Harold L. Moses, and John Mendelsohn, Editors; Committee on Cancer Clinical Trials and the NCI Cooperative Group Program; Institute of Medicine


• Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act (2012) (ISBN 0309225493) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Institute of Medicine


• Evolution of Translational Omics: Lessons Learned and the Path Forward (2012) (ISBN 0309224187) Christine M. Micheel, Sharly J. Nass, and Gilbert S. Omenn, Editors; Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials; Board on Health Care Services; Board on Health Sciences Policy; Institute of Medicine


• The Development of Medications for the Treatment of Opiate and Cocaine Addictions: Issues for the Government and Private Sector (1995) (ISBN 0309052440) Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, Editors; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Institute of Medicine


• Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Report (2006) (ISBN 030910078X) Committee on Clinical Trial Registries


• Safe Medical Devices for Children (2005) (ISBN 0309096316) Marilyn J. Field and Hugh Tilson, Editors, Committee on Postmarket Surveillance of Pediatric Medical Devices


• Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary (2009) (ISBN 0309128676) Margie Patlak, Sharyl Nass, and Christine Micheel, Rapporteurs, Institute of Medicine


• Rare Diseases and Orphan Products: Accelerating Research and Development (2011) (ISBN 0309158060) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Accelerating Rare Diseases Research and Orphan Product Development; Institute of Medicine


• Extending Medicare Reimbursement in Clinical Trials (2000) (ISBN 0309068886) Henry J. Aaron and Hellen Gelband, Editors; Committee on Routine Patient Care Costs in Clinical Trials for Medicare Beneficiaries, Institute of Medicine


• Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary (2011) (ISBN 0309219299) Victoria Weisfeld, Rebecca A. English, Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Food and Drug Administration Advisory Committees (1992) (ISBN 0309048370) Richard A. Rettig, Laurence E. Earley, and Richard A. Merrill, Editors; Committee to Study the Use of Advisory Committees, Institute of Medicine